PMS Study of MicardisPlus Tablet.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2014
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms PMS
- Sponsors Boehringer Ingelheim
- 31 Aug 2018 Biomarkers information updated
- 23 Oct 2009 Planned number of patients changed from 6764 to 6901 as reported by ClinicalTrials.gov.
- 28 Jan 2009 Actual initiation date (Sep 2003) added as reported by ClinicalTrials.gov.